Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China flag China · Delayed Price · Currency is CNY
6.13
-0.09 (-1.45%)
Jun 11, 2026, 3:04 PM CST

SHE:002412 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
160.91249.65128.0251.13145.4190.31
Trading Asset Securities
410.02333.8244.12203.87135.8249.24
Cash & Short-Term Investments
570.93583.45372.14255281.23139.55
Cash Growth
36.60%56.78%45.94%-9.33%101.52%34.75%
Accounts Receivable
399.04426.42425.03352.52320.57272.88
Other Receivables
102.480.940.880.6311.961.86
Receivables
501.52437.17442359.99332.53274.74
Inventory
215.02208.44222.88231.12246.62103.37
Prepaid Expenses
-9.136.93.8-1.23
Other Current Assets
90.3283.6279.2546.165.0316.51
Total Current Assets
1,3781,3221,123896.07865.4535.41
Property, Plant & Equipment
449.26455.72489.16515.61439.45470.75
Long-Term Investments
827.98836.44855.75841.81781.35707.95
Goodwill
14.7314.7314.7914.7914.7953.03
Other Intangible Assets
28.7628.6629.329.5433.7242.58
Long-Term Deferred Tax Assets
2.122.242.422.52.042.11
Long-Term Deferred Charges
14.7314.9414.4115.1315.7116.42
Other Long-Term Assets
18.0618.5218.2321.04138.47283.03
Total Assets
2,7332,6932,5472,3362,2912,111
Accounts Payable
33.9134.2841.6241.1143.6351.44
Accrued Expenses
17.449.9748.3162.5866.8348.31
Short-Term Debt
50.9857.584.5195.12120.15131.79
Current Income Taxes Payable
14.019.046.2311.644.614.52
Current Unearned Revenue
1.830.812.726.487.021.71
Other Current Liabilities
169.05136.72134.93138.51138113.33
Total Current Liabilities
287.17288.33318.32355.42380.24351.11
Long-Term Unearned Revenue
22.4923.0124.5416.8115.0316.22
Long-Term Deferred Tax Liabilities
0.830.8111.221.541.66
Total Liabilities
310.49312.15343.85373.46396.81368.99
Common Stock
503.2503.2503.2503.2503.2503.2
Additional Paid-In Capital
234.12234.12234.12234.12234.12232.77
Retained Earnings
1,6721,6341,4361,2151,161993.7
Comprehensive Income & Other
13.479.8730.4510.34-4.512.63
Total Common Equity
2,4232,3812,2031,9631,8941,742
Shareholders' Equity
2,4232,3812,2031,9631,8941,742
Total Liabilities & Equity
2,7332,6932,5472,3362,2912,111
Total Debt
50.9857.584.5195.12120.15131.79
Net Cash (Debt)
519.95525.95287.63159.88161.087.76
Net Cash Growth
55.29%82.86%79.90%-0.74%1975.89%-
Net Cash Per Share
1.031.050.570.320.320.02
Filing Date Shares Outstanding
503.2503.2503.2503.2503.2503.2
Total Common Shares Outstanding
503.2503.2503.2503.2503.2503.2
Working Capital
1,0911,033804.85540.65485.17184.3
Book Value Per Share
4.824.734.383.903.763.46
Tangible Book Value
2,3792,3382,1591,9191,8461,647
Tangible Book Value Per Share
4.734.654.293.813.673.27
Buildings
-648.15647.47644.48531.89533.67
Machinery
-231.59228.7223.66221.69218.69
Construction In Progress
-12.7710.89.086.095.26